West Pharmaceutical Services Inventory 2010-2024 | WST

West Pharmaceutical Services inventory from 2010 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.
  • West Pharmaceutical Services inventory for the quarter ending September 30, 2024 was $0.401B, a 7.09% decline year-over-year.
  • West Pharmaceutical Services inventory for 2023 was $0.435B, a 4.8% increase from 2022.
  • West Pharmaceutical Services inventory for 2022 was $0.415B, a 9.62% increase from 2021.
  • West Pharmaceutical Services inventory for 2021 was $0.378B, a 17.77% increase from 2020.
West Pharmaceutical Services Annual Inventory
(Millions of US $)
2023 $435
2022 $415
2021 $378
2020 $321
2019 $236
2018 $215
2017 $215
2016 $199
2015 $181
2014 $182
2013 $177
2012 $162
2011 $152
2010 $147
2009 $129
West Pharmaceutical Services Quarterly Inventory
(Millions of US $)
2024-09-30 $401
2024-06-30 $419
2024-03-31 $430
2023-12-31 $435
2023-09-30 $432
2023-06-30 $449
2023-03-31 $447
2022-12-31 $415
2022-09-30 $413
2022-06-30 $412
2022-03-31 $417
2021-12-31 $378
2021-09-30 $354
2021-06-30 $345
2021-03-31 $310
2020-12-31 $321
2020-09-30 $295
2020-06-30 $275
2020-03-31 $251
2019-12-31 $236
2019-09-30 $230
2019-06-30 $232
2019-03-31 $226
2018-12-31 $215
2018-09-30 $207
2018-06-30 $208
2018-03-31 $216
2017-12-31 $215
2017-09-30 $216
2017-06-30 $211
2017-03-31 $212
2016-12-31 $199
2016-09-30 $201
2016-06-30 $198
2016-03-31 $194
2015-12-31 $181
2015-09-30 $188
2015-06-30 $187
2015-03-31 $183
2014-12-31 $182
2014-09-30 $186
2014-06-30 $188
2014-03-31 $188
2013-12-31 $177
2013-09-30 $177
2013-06-30 $177
2013-03-31 $174
2012-12-31 $162
2012-09-30 $166
2012-06-30 $159
2012-03-31 $158
2011-12-31 $152
2011-09-30 $156
2011-06-30 $161
2011-03-31 $157
2010-12-31 $147
2010-09-30 $148
2010-06-30 $143
2010-03-31 $145
2009-12-31 $129
2009-09-30 $136
2009-06-30 $130
2009-03-31 $120
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $23.239B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.753B 21.76
Becton Dickinson (BDX) United States $65.165B 17.13
Cardinal Health (CAH) United States $29.869B 16.20
Labcorp (LH) United States $20.088B 16.66
Cooper (COO) United States $19.898B 28.32
Align Technology (ALGN) United States $17.037B 32.60
Henry Schein (HSIC) United States $9.198B 17.52
Merit Medical Systems (MMSI) United States $6.121B 31.26
DENTSPLY SIRONA (XRAY) United States $3.705B 10.08
CONMED (CNMD) United States $2.215B 18.48
Patterson (PDCO) United States $1.788B 9.43
STAAR Surgical (STAA) United States $1.312B 48.42
Lifevantage (LFVN) United States $0.165B 21.93
Pro-Dex (PDEX) United States $0.138B 27.49